The S&P 500 is closing in on its all-time high, and is likely to sail past it, as long as the Fed promises lower interest rates and the trade war calms down.Market Insiderread more
In a tweet, Trump said that he and Xi "had a very good telephone conversation," and that "our respective teams will begin talks prior to our meeting."Politicsread more
A Bloomberg News report Tuesday morning said the White House had looked at such a move in February.Marketsread more
President Donald Trump on Tuesday announced that he will not nominate acting Defense Secretary Patrick Shanahan to hold the position in a permanent capacity. Army Secretary...Politicsread more
Stocks surged after President Donald Trump said he will be meeting with his Chinese counterpart, Xi Jinping, at the upcoming G-20 summit.US Marketsread more
The move is part of a larger trend that saw the survey's 179 participants move away from risk and toward positions that reflect fear of a coming economic slowdown spurred by a...Marketsread more
Democratic frontrunner Joe Biden on Monday appealed to a billionaire Republican donor for fundraising help in his presidential campaign. But the financier, Trump-supporting...Politicsread more
Facebook and other groups are behind a new programming language for working with the Libra blockchain.Technologyread more
Tesla investors are regaining confidence in a quieter Elon Musk — even as they question the company's ability to hit its production goals for the second quarter.Autosread more
Long-time blockchain technologists say Facebook's Libra digital currency will introduce billions to cryptocurrencies, but the company's problems with trust and privacy remain...Technologyread more
Valisure, an online pharmacy company, told the FDA that high levels of dimethylformamide were found in valsartan, a drug produced by Swiss drugmaker Novartis and other...Health and Scienceread more
A Goldman Sachs stock portfolio that tracks industry-dominant "superstar" companies in the United States is beating the stock market over the last three years.
Among the stocks on the list: Procter & Gamble, which dominates consumer products, Altria Group, which dominates tobacco, along with Google parent Alphabet and PepsiCo. These companies often benefit from a high share of industry sales, strong pricing power and fat profit margins — all of which contribute to a compelling investment thesis, Goldman's chief U.S. equity strategist, David Kostin, wrote Tuesday.
The stock strategist added that companies with the highest share of industry sales have returned 49% since 2015 compared with 16% for companies with the lowest share after controlling for industry group.
"The market positioning of superstar firms often allows for greater bargaining power over consumers and workers and higher profitability," Kostin said in a note to clients. "Superstar firms have been one driver of the explosion in US corporate margins post-crisis."
The decline in the number of listed U.S. companies from 8,000 in 1996 to about 4,000 today through fewer initial public offerings and M&A has led to a concentration in a number of key industries, Goldman added.
While dominance has led to hefty bottom lines at a number of well-known conglomerates able to maintain sizable market share, regulatory troubles could be brewing for a few.
U.S. lawmakers are looking to crack down on big tech companies like Facebook, Amazon and Alphabet through congressional probes into their impact on public life. Both the Federal Trade Commission as well as the Department of Justice are also launching investigations into whether some of the nation's largest tech titans could be prosecuted under antitrust law or for violations of privacy.
That's kept their stocks under pressure, with Facebook and Alphabet each down at least 5% over the last month. And while regulators are still months, if not years, away from a conclusion, Kostin added investors should monitor developments closely.
"From a strategic perspective, we believe that uncertainty is still too high to recommend investors avoid stocks in the regulatory spotlight," he wrote. "But while the impact of regulation on today's stocks will be case-dependent, similarities among historical outcomes suggest that investors should reduce exposure to any stock that becomes subject to an antitrust lawsuit. In the past, stock valuations and share prices declined between lawsuit filing and resolution."